From: Systematic analyses of glutamine and glutamate metabolisms across different cancer types
Type | Cancer tissue (samples) | Control tissue (samples) |
---|---|---|
Bladder urothelial carcinoma (BLCA) | 182 | 18 |
Breast invasive carcinoma (BRCA) | 994 | 106 |
Colon adenocarcinoma (COAD) | 233 | 21 |
Head and neck squamous cell carcinoma (HNSC) | 303 | 37 |
Kidney chromophobe (KICH) | 66 | 25 |
Kidney renal clear cell carcinoma (KIRC) | 480 | 71 |
Kidney renal papillary cell carcinoma (KIRP) | 141 | 30 |
Liver hepatocellular carcinoma (LIHC) | 134 | 49 |
Lung adenocarcinoma (LUAD) | 470 | 58 |
Prostate adenocarcinoma (PRAD) | 195 | 45 |
Thyroid carcinoma (THCA) | 494 | 58 |